Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
Scott A. McConnell, Jaiprasath Sachithanandham, Nathan J. Mudrak, Xianming Zhu, Parsa Alba Farhang, Radamés J. B. Cordero, Maggie P. Wear, Janna R. Shapiro, Han-Sol Park, Sabra L. Klein, Aaron A.R. Tobian, Evan M. Bloch, David Sullivan, Andrew Pekosz, Arturo Casadevall
Topics & Concepts
NeutralizationConvalescent plasmaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)Spike ProteinAntibody2019-20 coronavirus outbreakCoronavirusBiologyMedicineImmunologyInfectious disease (medical specialty)OutbreakPathologyDiseaseSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchCOVID-19 Clinical Research Studies